Mukka Proteins Limited has informed the Exchange regarding Board meeting held on May 15, 2025.
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.9 pts less than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved audited standalone and consolidated financial results for Q4 and FY25. Standalone FY25 revenue from operations fell to Rs. 8,603.53 million from Rs. 12,308.20 million in FY24, a decline of about 30%, while FY25 standalone profit after tax dropped to Rs. 416.83 million from Rs. 627.56 million. Q4 FY25 standalone revenue grew roughly 41% year-on-year to Rs. 3,159.89 million, but Q4 PAT fell to Rs. 130.89 million from Rs. 223.17 million. The Board approved further investment of Rs. 1.045 crore in associate Ocean Proteins Private Limited, a corporate guarantee of Rs. 6.03 crore for subsidiary Ocean Aquatic Proteins LLC (Oman) with HDFC Bank, and a corporate guarantee of Rs. 10 crore for Shipwaves Online Limited with Vivriti Capital. It also appointed M/s. Chethan Nayak & Associates as Secretarial Auditor for five years (FY26–FY30) and noted an ongoing CGST litigation involving a demand of Rs. 9.82 crore which the company is contesting.
Full-year revenue and profit both fell sharply year-on-year and operating cash flow stayed deeply negative, which is a red flag for shareholders. On the positive side, Q4 showed strong revenue growth, the company is expanding through associate and subsidiary investments, and the auditor issued an unqualified opinion. Near-term stock sentiment may be weighed down by weak FY25 numbers, while longer-term focus will track execution of new investments and resolution of the tax dispute.